184 related articles for article (PubMed ID: 8502714)
21. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
22. HDV (delta factor) infection complicated with subacute fulminant hepatitis B. A morphological and immunohistochemical observation.
Cao H; Chen WZ; Du ZY
Chin Med J (Engl); 1990 Aug; 103(8):619-22. PubMed ID: 2242684
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the HBV carriers superinfected with HDV--influence of HDV superinfection on HBeAg/anti-HBe system and transaminase level].
Tamura I; Ichimura H; Itoh Y; Kurimura O; Kurimura T
Kansenshogaku Zasshi; 1988 Mar; 62(3):253-8. PubMed ID: 3147306
[No Abstract] [Full Text] [Related]
24. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus.
Farci P; Gerin JL; Aragona M; Lindsey I; Crivelli O; Balestrieri A; Smedile A; Thomas HC; Rizzetto M
JAMA; 1986 Mar; 255(11):1443-6. PubMed ID: 3951078
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
[No Abstract] [Full Text] [Related]
26. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
27. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
28. A possible misdiagnosis in patients presenting with acute HBsAg-negative hepatitis: the role of hepatitis delta virus.
Caredda F; Antinori S; Pastecchia C; Coppin P; Arici C; Fracassetti O
Infection; 1988; 16(6):358-9. PubMed ID: 3220581
[TBL] [Abstract][Full Text] [Related]
29. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine.
Fiedler M; Lu M; Siegel F; Whipple J; Roggendorf M
Vaccine; 2001 Sep; 19(32):4618-26. PubMed ID: 11535309
[TBL] [Abstract][Full Text] [Related]
30. HDV infection in Cyprus.
Eleftheriou A; Teloni F; Ioannou P
Prog Clin Biol Res; 1993; 382():277-85. PubMed ID: 8502692
[No Abstract] [Full Text] [Related]
31. Virus-associated receptor for polymerized human serum albumin and antibody to the receptor in HBV and in HDV infection.
Alberti A; Pontisso P; Fraiese A; Caredda F; Fattovich G; Tagariello G; Realdi G
Prog Clin Biol Res; 1987; 234():61-70. PubMed ID: 2819897
[No Abstract] [Full Text] [Related]
32. Acute delta hepatitis in Greek parenteral drug abusers.
Tassopoulos NC; Koutelou MG; Papatheodoridis GV; Kalantzakis YS; Hatzakis AE
Prog Clin Biol Res; 1993; 382():221-7. PubMed ID: 8502685
[No Abstract] [Full Text] [Related]
33. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell function during interferon treatment of delta hepatitis.
Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
[No Abstract] [Full Text] [Related]
36. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
37. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.
Fiedler M; Kosinska A; Schumann A; Brovko O; Walker A; Lu M; Johrden L; Mayer A; Wildner O; Roggendorf M
J Virol; 2013 Jul; 87(13):7708-16. PubMed ID: 23637419
[TBL] [Abstract][Full Text] [Related]
38. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
39. [Advance in the study on delta agent].
Xu XQ
Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):498-501. PubMed ID: 3931883
[No Abstract] [Full Text] [Related]
40. [HBV carriers and HDV superinfection--studies on the cases of HBsAg clearance].
Tamura I; Ichimura H; Tsubakio T; Kurimura O; Kurimura T
Kansenshogaku Zasshi; 1989 Feb; 63(2):103-8. PubMed ID: 2501426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
